ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway

Abstract Simple Summary: Cetuximab, which can be used in combination with other chemotherapies, is widely used as a standard of…